Q&A: Liraglutide outperforms colesevelam in reducing stool frequency in bile acid diarrhea

Liraglutide reduced stool frequency in a small subset of patients with bile acid diarrhea and warrants consideration as a potential new treatment modality, according to research in The Lancet Gastroenterology and Hepatology.Researchers aimed to investigate the safety and efficacy of liraglutide, a glucagon-like peptide 1 receptor agonist, in patients with bile acid diarrhea, which is…

Cancer complications topped reasons for GI tract surgery prior to hospice admission

Most gastrointestinal tract surgeries performed before hospice admission were for urgent or emergent complications of cancer and required patient hospitalization in the preceding 3 years, according to a California-based cohort study.The researchers also found that those readmitted to the hospital after hospice enrollment tended to be from underserved groups.“These findings suggest multiple opportunities for advance…